TrialRheumatology (Oxford, England)2025

An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP.

Ariane L Herrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.